Clinical Study Results
The table below shows the treatments for each group.
Group 1 Group 2 Group 3
What treatments • 246 participants • 237 participants got • 240 participants got
were given? got durvalumab and durvalumab alone an SOC treatment
tremelimumab
How were the • Durvalumab and • Durvalumab was • SOC treatment was
treatments tremelimumab given by IV given by IV or
given? were given by IV as a tablet or
capsule
When were the Participants got Participants got Participants got an
treatments durvalumab and durvalumab: SOC treatment:
given? tremelimumab: • 2 times each cycle • throughout each
• 1 time each cycle for until their cancer cycle until their
4 cycles until their got worse cancer got worse
cancer got worse
After 4 cycles,
participants could get:
• durvalumab 2 times
each cycle until their
cancer got worse
At the end of the study, the doctors checked the participants’ overall health and tumors. The
doctors also gave the participants surveys that asked them how they were feeling.
After this visit, the doctors continued checking the participants’ overall health and tumors every
4 weeks until the study finished.
What were the results of the study?
This is a summary of the main results from this study overall. The results each participant had
might be different and are not in this summary. A full list of the questions the researchers wanted
to answer can be found on the websites listed at the end of this summary. If a full report of the
study results is available, it can also be found on these websites.
Other studies may provide new information or different results. Always talk to a doctor before
making any treatment changes.
Even though 13 of the 736 participants did not get study treatment, the researchers were still
able to study their overall results. So, the below results are for all 736 participants.
4